Corrigendum to: 'miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression' [Biomedicine & Pharmacotherapy (71), (2015) 112–118]
- Resource Type
- Source
- Biomedicine & Pharmacotherapy. 84:1440-1441
- Subject
Pharmacology Temozolomide Pharmacotherapy business.industry medicine General Medicine medicine.disease business Biomedicine Glioblastoma medicine.drug - Language
- ISSN
- 0753-3322